- info@novaerus.ie
- +353 (1) 255 1536
To evaluate the efficacy of the NV1050 on removing Influenza A.
Testing of the NV1050 was conducted in a 28.5 m3 environmental test chamber. The chamber was preconditioned to 20±3ºC and 50±10% relative humidity prior to commencement of the tests. For the test runs, the NV1050 was placed on the floor in the centre of the chamber.
The NV1050 was effective in reducing airborne Influenza A aerosols in the test chamber, reaching 99.9% airborne virus reduction within the first 10 – 20 minutes of operation at max speed.
About Us
Novaerus is on a mission to reduce indoor airborne pollutants that lead to infection, allergies, asthma, and odour.
The patented plasma nanotechnology used in Novaerus portable devices was invented in Ireland in 2006.
Novaerus Devices
Stay Connected to Novaerus
To keep up to date with all developments and for the latest research and scientifically proven results please follow us on LinkedIn, Facebook and Youtube.
